greeksoup/ stock research

Merck (MRK) FY2010 results: revenue $46.0 billion, up 67.7% on the year

Merck & Co., Inc. (MRK) reported revenue of $46.0 billion for fiscal 2010, the year ended 31 December 2010, up 67.7% on the year before. Net income was $861 million, down 93.3%, and diluted earnings per share $0.28. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2011.

Revenue
$46.0 billion
+67.7% on the year
FY2007FY2010
Operating margin
n/a
FY2007FY2010
Net income
$861 million
-93.3% on the year
FY2007FY2010
Diluted EPS
$0.28
-95.0% on the year
FY2007FY2010

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2010FY2009FY2008On the yearLast 8 years
Revenue45,98727,42823,850+67.7%
Cost of revenue18,3969,0195,582+104.0%
Gross profit27,59118,40918,268+49.9%
Gross margin60.0%67.1%76.6%
Research and development11,1115,8454,805+90.1%
Selling, general and administrative13,1258,5437,377+53.6%
Interest expense715460251+55.4%
Pre-tax income1,65315,290n/a-89.2%
Income tax6712,2681,999-70.4%
Effective tax rate40.6%14.8%n/a
Net income86112,9017,808-93.3%
Net margin1.9%47.0%32.7%
Diluted EPS$0.28$5.65$3.63-95.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2010FY2009FY2008On the yearLast 8 years
Operating cash flow10,8223,3926,572+219.0%
Capital expenditure1,6781,4611,298+14.9%
Free cash flow9,1441,9315,273+373.4%
Free cash flow margin19.9%7.0%22.1%
Cash from investing-3,4973,156-1,834
Cash from financing-5,441-1,638-5,522
Depreciation and amortisation7,3812,5761,631+186.5%
Share-based compensation509416348+22.5%
Buybacks1,5930.02,725
Dividends paid4,7343,2153,278+47.2%
Dividend per share$1.52$1.52$1.520.0%
Diluted shares, weighted3,120m2,273m2,143m+37.3%

Balance sheet

$ millionFY2010FY2009FY2008On the yearLast 8 years
Shareholders' equity54,37659,05818,758-7.9%
Non-controlling interest2,4292,4272,409+0.1%
Debt17,88217,5003,943+2.2%
Other liabilities31,09433,32922,085-6.7%
Total liabilities and equity105,781112,31447,196-5.8%
Fixed assets17,08218,27412,000-6.5%
Goodwill12,37812,0381,439+2.8%
Intangible assets39,45647,757525-17.4%
Investments3,4767257,609+379.2%
Cash and equivalents10,9009,3114,368+17.1%
Receivables7,3446,6032,816+11.2%
Inventory5,8688,0552,091-27.2%
Other assets9,2779,55016,347-2.9%
Total assets105,781112,31447,196-5.8%

10-K for the year ended 31 December 2010, filed 28 February 2011: the filing.